Reaction

Sinus Operation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,346 reports · 56 co-occurring drugs

As of the last recalculation, Sinus Operation appears in 2,346 FAERS reports alongside 56 co-occurring drug terms. The strongest observed disproportionality signal is DORNASE ALFA (PRR 55.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dornase Alfa	117	55.7	56.0
Ciclesonide	57	38.0	38.2
Lumacaftor And Ivacaftor	33	34.6	34.8
Mepolizumab	132	24.9	25.0
Elexacaftor, Tezacaftor, And Ivacaftor	34	24.5	24.6
Ivacaftor	18	20.3	20.3
Tobramycin	42	15.8	15.8
Calcium, Magnesium, Potassium, And Sodium Oxybates	14	14.5	14.5
Tobramycin Sulfate	20	14.4	14.5
Tobramycin Solution	19	14.1	14.2
Azelastine	26	13.0	13.0
Budesonide	82	12.8	12.8
Mupirocin	18	11.9	11.9
Mupirocin Calcium	18	11.7	11.7
Pancrelipase	49	11.5	11.5
Fluticasone Furoate And Vilanterol Trifenatate	41	10.3	10.3
Hyoscyamine Sulfate	10	9.7	9.7
Fluticasone Propionate And Salmeterol Xinafoate	64	9.7	9.7
Etonogestrel And Ethinyl Estradiol	21	8.5	8.5
Fluticasone Propionate	117	8.4	8.4
Butalbital, Acetaminophen, And Caffeine	10	8.4	8.4
Acetaminophen, Chlorpheniramine Maleate, Phenylephrine Hcl	45	8.1	8.1
Mometasone Furoate And Formoterol Fumarate Dihydrate	14	8.0	8.0
Montelukast Sodium	105	8.0	8.0
Sodium Oxybate	53	7.3	7.3
Thyroid, Porcine	8	6.7	6.7
Buspirone Hydrochloride	8	6.5	6.5
Chlorthalidone	8	6.1	6.1
Ibrutinib	54	6.0	6.1
Montelukast	56	6.0	6.0
Upadacitinib	54	6.0	6.0
Dupilumab	291	6.0	6.0
Vancomycin	38	5.9	5.9
Bimekizumab	14	5.9	5.9
Vancomycin Hydrochloride	42	5.7	5.7
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	13	5.6	5.6
Naproxen Sodium, Pseudoephedrine Hydrochloride	13	5.6	5.6
Fluticasone Propionate And Salmeterol	26	5.6	5.6
Risankizumab-Rzaa	50	5.5	5.5
Eptinezumab-Jjmr	5	4.9	4.9
Levocetirizine Dihydrochloride	13	4.8	4.8
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate	19	4.8	4.8
Linaclotide	14	4.7	4.7
Armodafinil	11	4.6	4.6
Icosapent Ethyl	4	4.2	4.2
Niraparib	10	4.0	4.0
Vilazodone Hydrochloride	4	3.9	3.9
Riociguat	13	3.6	3.6
Vibegron	3	3.3	3.3
Cenegermin-Bkbj	4	2.9	2.9
Rimegepant Sulfate	4	2.8	2.8
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	12	2.6	2.6
Esketamine Hydrochloride	4	2.0	2.0
Relugolix	5	1.9	1.9
Pirfenidone	8	1.7	1.7
Nirmatrelvir And Ritonavir	8	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.